← Every firm
The Harvard Drug Group LLC FDA Recalls
8 recalls on file across drugs, 0 of them Class I and 8 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and DistributClass IIJun 16, 2026Subpotent Drug |
| Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per carton, Rx only, PacClass IIApr 9, 2026Failed Capsule Specifications: Out of specification results |
| Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and DiClass IIMar 24, 2026Failed Dissolution Specifications |
| Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: MajClass IIFeb 17, 2026Defective container; inadequately sealed blister packaging. |
| Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major PharClass IIOct 10, 2025Failed Impurities/Degradation Specifications: an out of spec |
| Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by: Major PharmacClass IIOct 10, 2025Failed Impurities/Degradation Specifications: an out of spec |
| Gabapentin Capsules, USP, 100 mg, 10 capsules (10x1) per bag, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALClass IIJun 19, 2025Defective container; blister packaging inadequately sealed. |
| Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOClass IIJun 19, 2025Defective container; blister packaging inadequately sealed. |